Search Results - "Pelletier, S.J."

Liver Transplantation in the United States, 1999–2008 by Thuluvath, P. J., Guidinger, M. K., Fung, J. J., Johnson, L. B., Rayhill, S. C., Pelletier, S. J.

“…Changes in organ allocation policy in 2002 reduced the number of adult patients on the liver transplant waiting list, changed the characteristics of transplant…”
Get full text

Photodynamic Therapy Provides Local Control of Cholangiocarcinoma in Patients Awaiting Liver Transplantation by Cosgrove, N. D., Al‐Osaimi, A. M., Sanoff, H. K., Morris, M. M., Read, P. W., Cox, D. G., Mann, J. A., Argo, C. K., Berg, C. L., Pelletier, S. J., Maluf, D. G., Wang, A. Y.

“…Many transplant centers use endoscopically directed brachytherapy to provide locoregional control in patients with otherwise incurable cholangiocarcinoma (CCA)…”
Get full text

Portal vein stenosis in adult whole graft liver transplant recipients: primary management with transhepatic angioplasty by Saad, W.E, Khaja, M.S, Schwaner, S.L, Davies, M.G, Nicholson, D, Pelletier, S.J, Al-Osaimi, A.M, Angle, J.F, Matsumoto, A.H

Get full text

Comparison of Histidine‐Tryptophan‐Ketoglutarate and University of Wisconsin Preservation in Renal Transplantation by Lynch, R. J., Kubus, J., Chenault, R. H., Pelletier, S. J., Campbell, D. A., Englesbe, M. J.

“…Histidine‐tryptophan‐ketoglutarate (HTK) is replacing University of Wisconsin (UW) solution as the preservation fluid for renal allografts in many centers, but…”
Get full text

Seasonal variation in surgical outcomes as measured by the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) by Englesbe, M.J, Pelletier, S.J, Magee, J.C

Get full text

P252 by Ammori, J.B, Sigakis, M, O’Reilly, M, Pelletier, S.J

Get full text

Outcomes after LT in susceptible HBV recipients using grafts from donors with HBV/HCV co-infection by Robinson, T.J., Vargas, P.A., Cunningham, M., Bernstein, K.M., Pelletier, S.J.

Get full text

Liver transplant from deceased donors with HBV/HCV coinfection - utilization and recipient outcomes by Cunningham, M., Vargas, P.A., Bernstein, K.M., Robinson, T.J., Pelletier, S.J.

Get full text

PROviding Better ACcess To ORgans: A comprehensive overview of organ‐access initiatives from the ASTS PROACTOR Task Force by Hobeika, M. J., Miller, C. M., Pruett, T. L., Gifford, K. A., Locke, J. E., Cameron, A. M., Englesbe, M. J., Kuhr, C. S., Magliocca, J. F., McCune, K. R., Mekeel, K. L., Pelletier, S. J., Singer, A. L., Segev, D. L.

“…The American Society of Transplant Surgeons (ASTS) PROviding better Access To Organs (PROACTOR) Task Force was created to inform ongoing ASTS organ access…”
Get full text

Educational ExhibitAbstract No. 341 - Portal vein stenosis in adult whole graft liver transplant recipients: primary management with transhepatic angioplasty by Saad, W.E., Khaja, M.S., Schwaner, S.L., Davies, M.G., Nicholson, D., Pelletier, S.J., Al-Osaimi, A.M., Angle, J.F., Matsumoto, A.H.

“…Endovascular management of portal vein stenosis (PVS) in adult whole graft (not split graft) liver transplantation is rarely reported. Almost all of the…”
Get full text

Recovery and Utilization of Deceased Donor Kidneys from Small Pediatric Donors by Pelletier, S. J., Guidinger, M. K., Merion, R. M., Englesbe, M. J., Wolfe, R. A., Magee, J. C., Sollinger, H. W.

“…The optimal use of kidneys from small pediatric deceased donors remains undetermined. Using data from the Scientific Registry of Transplant Recipients, 2886…”
Get full text

The Effects of Donor and Recipient Practices on Transplant Center Finances by Englesbe, M. J., Ads, Y., Cohn, J. A., Sonnenday, C. J., Lynch, R., Sung, R. S., Pelletier, S. J., Birkmeyer, J. D., Punch, J. D.

“…Over the past several years we have noted a marked decrease in this profitability of our kidney transplant program. Our hypothesis is that this reduction in…”
Get full text

Risk Factors for Urinary Complications After Renal Transplantation by Englesbe, M. J., Dubay, D. A., Gillespie, B. W., Moyer, A. S., Pelletier, S. J., Sung, R. S., Magee, J. C., Punch, J. D., Campbell, D. A., Merion, R. M.

“…Urinary complications are common following renal transplantation. The aim of this study is to evaluate the risk factors associated with renal transplant…”
Get full text

Who Pays for Biliary Complications Following Liver Transplant? A Business Case for Quality Improvement by Englesbe, M. J., Dimick, J., Mathur, A., Ads, Y., Welling, T. H., Pelletier, S. J., Heidt, D. G., Magee, J. C., Sung, R. S., Punch, J. D., Hanto, D. W., Campbell, D. A.

“…We use biliary complication following liver transplantation to quantify the financial implications of surgical complications and make a case for surgical…”
Get full text

A Call for a National Transplant Surgical Quality Improvement Program by Englesbe, M. J., Pelletier, S. J., Kheterpal, S., O'Reilly, M., Campbell, D. A.

“…The severity of illness in transplant patients and the complexity of transplant operations results in significant postoperative morbidity and mortality…”
Get full text

P252: Impact of strict intra-operative blood glucose control during liver transplantation by Ammori, J.B., Sigakis, M., O’Reilly, M., Pelletier, S.J.

Get full text

Financial Implications of Pancreas Transplant Complications: A Business Case for Quality Improvement by Cohn, J. A., Englesbe, M. J., Ads, Y. M., Paruch, J. L., Pelletier, S. J., Welling, T. H., Sonnenday, C. J., Magee, J. C., Punch, J. D., Campbell, D. A., Sung, R. S.

“…We quantified the financial implications of surgical complications following pancreas transplantation. We reviewed medical and financial records of 49 pancreas…”
Get full text

Should heart, lung, and liver transplant recipients receive immunosuppression induction for kidney transplantation? by Ranney, D.N., Englesbe, M.J., Muhammad, W., Al-Holou, S.N., Park, J.M., Pelletier, S.J., Punch, J.D., Lynch, R.J.

“…Ranney DN, Englesbe MJ, Muhammad W, Al‐Holou SN, Park JM, Pelletier SJ, Punch JD, Lynch RJ. Should heart, lung, and liver transplant recipients receive…”
Get full text

Preliminary Analysis of Early Outcomes of a Prospective, Randomized Trial of Complete Steroid Avoidance in Liver Transplantation by Pelletier, S.J., Vanderwall, K., Debroy, M.A., Englesbe, M.J., Sung, R.S., Magee, J.C., Fontana, R.J., Punch, J.D.

“…Steroids are a mainstay in liver transplantation for induction and maintenance immunosuppression but are associated with significant adverse effects. While…”
Get full text

Advances in pre- and posttransplant management of hepatitis B virus by Pelletier, S.J, Pruett, T.L

Get full text